Computer-aided drug design provides broad structural modifications to evolving bioactive molecules without an immediate requirement to observe synthetic restraints or tedious protocols. Subsequently, the most promising guidelines with regard to synthetic and biological resources may be focused on upcoming steps. Molecular docking is common drug design techniques since it predicts ligand-receptor interaction modes and associated binding affinities.
View Article and Find Full Text PDF